Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Alzheimer's Association International Conference (AAIC) 2024 was held in Philadelphia, PA, and online, from 28 July - 01 August. This meeting brought together dementia researchers to discuss the latest advances.

AAIC 2024

28 Jul–01 August 2024 | Philadelphia, PA

AAIC 2024

28 Jul–01 August 2024 | Philadelphia, PA
The Alzheimer's Association International Conference (AAIC) 2024 was held in Philadelphia, PA, and online, from 28 July - 01 August. This meeting brought together dementia researchers to discuss the latest advances.
Comparing different assays for detecting AD plasma biomarkers 1:31
Comparing different assays for detecting AD plasma biomarkers
Gemma Salvadó • 20 Aug 2024
The association between infectious diseases and dementia 6:13
The association between infectious diseases and dementia
Cornelia van Duijn • 26 Jul 2024
Using plasma ptau217 to select cognitively unimpaired participants for AD prevention trials 4:34
Using plasma ptau217 to select cognitively unimpaired participants for AD prevention trials
Gemma Salvadó • 20 Aug 2024
Comparing plasma ptau217 with CSF biomarkers for predicting tau PET status 1:02
Comparing plasma ptau217 with CSF biomarkers for predicting tau PET status
Gemma Salvadó • 20 Aug 2024
Using blood testing to improve the accuracy of AD diagnosis in primary and secondary care settings 3:32
Using blood testing to improve the accuracy of AD diagnosis in primary and secondary care settings
Suzanne Schindler • 13 Aug 2024
The accuracy of plasma tau217 biomarkers in detecting AD pathology 2:27
The accuracy of plasma tau217 biomarkers in detecting AD pathology
Gemma Salvadó • 20 Aug 2024
Looking back over the first year of lecanemab use in AD: benefits and challenges 4:19
Looking back over the first year of lecanemab use in AD: benefits and challenges
Suzanne Schindler • 13 Aug 2024
A head-to-head comparison of AD blood tests reveals the value of ptau217 7:08
A head-to-head comparison of AD blood tests reveals the value of ptau217
Suzanne Schindler • 13 Aug 2024
The evolution of biomarker testing in AD: CSF, blood, and PET 5:25
The evolution of biomarker testing in AD: CSF, blood, and PET
Suzanne Schindler • 13 Aug 2024
The minimum acceptable performance of blood biomarker tests for diagnosing AD 5:12
The minimum acceptable performance of blood biomarker tests for diagnosing AD
Suzanne Schindler • 13 Aug 2024
The clinical use of tau-PET: its value and limitations 1:50
The clinical use of tau-PET: its value and limitations
Cécile Tissot • 13 Aug 2024
Highlights from AAIC 2024: tau-PET harmonization and the DIAN-TU trial 2:09
Highlights from AAIC 2024: tau-PET harmonization and the DIAN-TU trial
Cécile Tissot • 13 Aug 2024
Improving tau-PET harmonization: the HEAD study 5:57
Improving tau-PET harmonization: the HEAD study
Cécile Tissot • 13 Aug 2024
The spread of oligomeric tau through synapses in Alzheimer’s disease 8:11
The spread of oligomeric tau through synapses in Alzheimer’s disease
Tara Spires-Jones • 5 Aug 2024

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals